Furuta Milano — SEC Form 4 filings
SEC reporting owner CIK 2111400. 2 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2026-04-28 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD (TAK) | Chief Financial Officer, Director | 2 | — | — | 7 |
Form 4 filings — Furuta Milano
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/award (A): 12,300 @ $0 · Disposition to issuer (D): 16,619 (derivative) @ $4,931.50 · Grant/award (A): 4,288 (derivative) @ $0 · Grant/award (A): 4,288 (derivative) @ $0 · Grant/award (A): 4,288 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/award (A): 7,800 @ $0 · Grant/award (A): 7,814 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2111400 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →